His primary areas of study are Microbiology, Legionella pneumophila, Typing, Bordetella pertussis and Serotype. His Microbiology research is multidisciplinary, incorporating perspectives in Antiserum, Enterobacteriaceae, Escherichia coli, Agar and Genotype. In his study, which falls under the umbrella issue of Legionella pneumophila, Effector is strongly linked to Gene.
The concepts of his Typing study are interwoven with issues in Infectious disease, Pathology, Clinical microbiology, Medical physics and Typing methods. His work carried out in the field of Bordetella pertussis brings together such families of science as Whooping cough and Pertactin. His Serotype study combines topics from a wide range of disciplines, such as Legionella and Molecular epidemiology.
Norman K. Fry spends much of his time researching Microbiology, Serotype, Virology, Bordetella pertussis and Pediatrics. His research in Microbiology is mostly concerned with Typing. His biological study spans a wide range of topics, including Pneumococcal conjugate vaccine, Streptococcus pneumoniae, Pneumococcal disease, Antigen and Internal medicine.
Norman K. Fry works mostly in the field of Virology, limiting it down to topics relating to Immunoassay and, in certain cases, Multiplex. His Bordetella pertussis study also includes fields such as
Whooping cough and related Pertussis vaccine and Serology,
Pertactin which is related to area like Virulence,
Pulsed-field gel electrophoresis which intersects with area such as Allele. His Pediatrics study also includes
Vaccination together with Outbreak and Cohort,
Incidence that intertwine with fields like Epidemiology.
Norman K. Fry mainly focuses on Serotype, Incidence, Streptococcus pneumoniae, Pneumococcal conjugate vaccine and Pediatrics. His Serotype study improves the overall literature in Microbiology. The study incorporates disciplines such as Epidemiology, Disease, Invasive disease, Public health and Pneumococcal infections in addition to Incidence.
His Streptococcus pneumoniae study integrates concerns from other disciplines, such as Odds ratio, Antigen and Virology. His Pneumococcal conjugate vaccine research incorporates elements of Cohort study and Pneumonia. His Pediatrics research is multidisciplinary, incorporating elements of Toxigenic Corynebacterium diphtheriae, Survival analysis, Contact tracing and Vaccination.
Norman K. Fry mostly deals with Serotype, Pneumococcal conjugate vaccine, Incidence, Pneumococcal disease and Pediatrics. Serotype is a subfield of Microbiology that he tackles. His Pneumococcal conjugate vaccine research integrates issues from Carriage and Internal medicine.
His studies deal with areas such as Epidemiology, Pneumococcal infections and Vaccination as well as Incidence. His Vaccination research is multidisciplinary, relying on both Pneumococcal conjugate vaccination and Cohort. Pediatrics and Public health are frequently intertwined in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the validation and application of typing methods for use in bacterial epidemiology
A. van Belkum;P.T. Tassios;L. Dijkshoorn;S. Haeggman.
Clinical Microbiology and Infection (2007)
Effectiveness of maternal pertussis vaccination in England: an observational study
Gayatri Amirthalingam;Nick Andrews;Helen Campbell;Sonia Ribeiro.
The Lancet (2014)
Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila
Valeria Gaia;Norman K. Fry;Baharak Afshar;P. Christian Lück.
Journal of Clinical Microbiology (2005)
A Case-Control Study to Estimate the Effectiveness of Maternal Pertussis Vaccination in Protecting Newborn Infants in England and Wales, 2012–2013
Gavin Dabrera;Gayatri Amirthalingam;Nick Andrews;Helen Campbell.
Clinical Infectious Diseases (2015)
Addition of neuA, the Gene Encoding N-Acylneuraminate Cytidylyl Transferase, Increases the Discriminatory Ability of the Consensus Sequence-Based Scheme for Typing Legionella pneumophila Serogroup 1 Strains
Sandra Ratzow;Valeria Gaia;Jürgen Herbert Helbig;Norman K. Fry.
Journal of Clinical Microbiology (2007)
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study
Shamez N Ladhani;Shamez N Ladhani;Sarah Collins;Abdelmajid Djennad;Carmen L Sheppard.
Lancet Infectious Diseases (2018)
The use of 16S ribosomal RNA analyses to investigate the phylogeny of the family Legionellaceae.
N K Fry;S Warwick;N A Saunders;T M Embley.
What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories
N. Guiso;G. Berbers;N. K. Fry;Q. He.
European Journal of Clinical Microbiology & Infectious Diseases (2011)
Global Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination
Marieke J. Bart;Simon R. Harris;Abdolreza Advani;Yoshichika Arakawa.
Distribution of Legionella pneumophila serogroups, monoclonal antibody subgroups and DNA sequence types in recent clinical and environmental isolates from England and Wales (2000–2008)
T. G. Harrison;B. Afshar;N. Doshi;N. K. Fry.
European Journal of Clinical Microbiology & Infectious Diseases (2009)
Journal of Medical Microbiology
(Impact Factor: 3.196)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: